Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)

Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)

Objectives The choice of drug treatment in advanced soft tissue sarcoma (STS) continues to be a challenge regarding efficacy, quality of life (QoL) and toxicity. Unlike other cancer types, where integrating patient-reported outcomes (PRO) has proven to be beneficial for QoL, there is no such evidenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Bernd Kasper, Viktor Grünwald, Martin Bornhäuser, Uwe Pelzer, Leopold Hentschel, Stephan Richter, Hans-Georg Kopp, Annegret Kunitz, Torsten Kessler, Jens Marcus Chemnitz, Ulrich Schuler, Janet Freitag, Andrea Schilling, Beate Hornemann, Karin Arndt, Markus Kajo Schuler
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e035546.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/10/8/e035546.full

Similar Items